Trader consensus on Polymarket favors acquisitions in biotech and fintech amid a surge in M&A rumors, with Viking Therapeutics drawing attention as a top GLP-1 obesity drug target following recent CNBC reports highlighting big pharma's acquisition hunt for pipeline bolstering. PayPal faces speculation after February disclosures of Stripe's early interest in its payments platform to enhance digital infrastructure, while Perplexity AI's $20 billion valuation fuels bets on AI search talent grabs by Big Tech like Apple. Ubisoft lingers amid ongoing Tencent stake-building and private equity overtures. Key catalysts include Q2 earnings, clinical trial data for VK2735, and deal antitrust reviews, underscoring competitive dynamics in AI, fintech, and therapeutics before year-end resolution.
Experimental AI-generated summary referencing Polymarket data · UpdatedWhich companies will be acquired before 2027?
Which companies will be acquired before 2027?
$17,304,848 Vol.

Caesars Entertainment
60%

Pizza Hut
39%

Viking Therapeutics
31%

Perplexity AI
29%

PayPal
27%

Ubisoft
27%

GitLab
24%

BP
22%

Snapchat
17%

Nebius Group
17%

Lovable
16%

Anthropic
11%

Zoom Video Communications
10%

OpenAI
10%
$17,304,848 Vol.

Caesars Entertainment
60%

Pizza Hut
39%

Viking Therapeutics
31%

Perplexity AI
29%

PayPal
27%

Ubisoft
27%

GitLab
24%

BP
22%

Snapchat
17%

Nebius Group
17%

Lovable
16%

Anthropic
11%

Zoom Video Communications
10%

OpenAI
10%
Mergers where the listed company is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between the listed company and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from the listed company and/or its leadership; however, a consensus of credible reporting will also be used.
Market Opened: Nov 24, 2025, 12:48 PM ET
Resolver
0x65070BE91...Mergers where the listed company is subsumed by another entity will count toward a "Yes" resolution.
An announced agreement between the listed company and an acquiring entity will qualify for a “Yes” resolution, regardless of whether the acquisition is ultimately completed.
The primary resolution source for this market is official information from the listed company and/or its leadership; however, a consensus of credible reporting will also be used.
Resolver
0x65070BE91...Trader consensus on Polymarket favors acquisitions in biotech and fintech amid a surge in M&A rumors, with Viking Therapeutics drawing attention as a top GLP-1 obesity drug target following recent CNBC reports highlighting big pharma's acquisition hunt for pipeline bolstering. PayPal faces speculation after February disclosures of Stripe's early interest in its payments platform to enhance digital infrastructure, while Perplexity AI's $20 billion valuation fuels bets on AI search talent grabs by Big Tech like Apple. Ubisoft lingers amid ongoing Tencent stake-building and private equity overtures. Key catalysts include Q2 earnings, clinical trial data for VK2735, and deal antitrust reviews, underscoring competitive dynamics in AI, fintech, and therapeutics before year-end resolution.
Experimental AI-generated summary referencing Polymarket data · Updated



Beware of external links.
Beware of external links.
Frequently Asked Questions